Rimegepant to prevent predictable trigger-induced migraines
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had migraines for at least a year, and they usually start before age 50.
- You get 2 to 8 moderate or severe migraine attacks each month, and each attack lasts 4 to 72 hours if untreated.
- You can tell when a migraine is coming on, especially after a known trigger like exercise, alcohol, stress, or travel.
- You are not currently using a daily gepant medication (like atogepant or rimegepant) for prevention.
- You have not used opioid painkillers on 5 or more days per month for the past 3 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This observational study looks at health outcomes for moms, babies, and infants after rimegepant is used during pregnancy for migraine. It may help doctors understand potential risks or reassuring safety information for future pregnancies.
This study looks at blood samples from people with migraine to find proteins and other markers that might explain why migraines happen. The goal is to better understand migraine, which could help find better treatments in the future.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.